Trial Profile
Rotation to OpTimal Albuminuria Treatment Evaluation: A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Linagliptin (Primary) ; Losartan (Primary) ; Sulodexide (Primary)
- Indications Diabetes mellitus; Proteinuria
- Focus Therapeutic Use
- Acronyms ROTATE
- 22 Jul 2016 New trial record